2017 China (Lianyungang) International Conference on Medical Technology was held on November 16, 2017 in Lianyungang, Jiangsu, China. With the theme of "Converging Medical Science and Technology Innovation and Cohesion Health Industry Development", more than 300 well-known academicians and experts from all over the world have gathered in Lianyungang to communicate for pharmaceutical technology innovation and industrial development.
(In the photo: Dr. Guangji Wang (3rd from the left), Academician of Chinese Academy of Engineering; Dr. Lianda Li (4th from the left), Academician of Chinese Academy of Engineering & Professor of Chinese Academy of Traditional Chinese Medicine; Dr. Carlo M. Croce (6th from the left), Academician of the National Academy of Sciences & Academician of the National Academy of Medicine & Academician of the National Cancer Institute of the United States & Academician of the Italian National Academy of Sciences & Professor of the Ohio State University; Dr. Xingshi Yang (7th from the left), Municipal secretary of Lianyungang; Dr. Peixuan Guo (7th from the right), Sylvan G. Frank Endowed Chair in Pharmaceutics and Drug Delivery & Professor of the Ohio State University; Dr. Haibo Hu (4th from the right), CEO of Nanobio Delivery Pharmaceutical Co., Ltd.; chairs from overseas Chinese professional societies; and officers from Lianyungang government and Lianyungang Food and Drug Administration etc.)
(Professor Peixuan Guo giving the talk about RNA nanotechnology for targeted therapy.)
During the conference, Prof. Peixuan Guo from the Ohio State University has introduced the next generation of targeted drug delivery system through RNA nanotechnology platform, Academician Carlo M. Croce from the Ohio State University has reported the strategies of the identification of new drug targets and biomarkers for cancer diagnosis. Other sections include international scientific forums, International medical science and technology innovation product exhibition, and project roadshows to promote the exchange of cutting-edge technology and the transformation and translation of innovative elements in the pharmaceutical sciences.